Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Many studies have shown that angiogenesis plays an important role in the process of cancer development and progression. Vascular endothelial growth factor (VEGF) has a potent angiogenic activity, and cyclooxygenase-2 (COX-2) supports angiogenesis by regulated production of angiogenic factors, including VEGF. The purpose of this study was to examine the expression of VEGF in combination with COX-2 and CD34, their correlation with various clinicopathological factors, and their prognostic significance in human gastric carcinoma.

Methods

Specimens from 169 patients with different grade and stage gastric carcinoma were investigated by immunohistochemistry for COX-2 and VEGF expression. Tumor microvessel density was assessed with CD34 immunostaining. Correlations between the expression of VEGF, COX-2, CD34, and various clinicopathological factors were studied. The effect of these proteins on patient survival was determined.

Results

COX-2 and VEGF were positively expressed in 36.7% and 50.3% of the patients, respectively. Positive correlation was found between VEGF and COX-2 and between VEGF and CD34. VEGF expression was correlated with depth of invasion; metastatic lymph nodes; lymphatic and venous invasion; and tumor, node, metastasis system stage. Patients with positive staining for VEGF showed far lower disease-free (64.9% vs. 81.3%) and overall (58.3% vs. 76.9%) survival rates than VEGF-negative patients. In multivariate analysis, only tumor location, depth of invasion, and lymph node metastasis were shown to be independent prognostic factors.

Conclusions

VEGF expression correlates with angiogenesis and tumor progression and is a valuable prognostic factor in patients with gastric carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

REFERENCES

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108

    Article  PubMed  Google Scholar 

  2. Lambert L, Guilloux A, Oshima A, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and USA. Int J Cancer 2002;97:811–8

    Article  PubMed  CAS  Google Scholar 

  3. Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001;61:253–70

    Article  PubMed  CAS  Google Scholar 

  4. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57

    Article  PubMed  CAS  Google Scholar 

  5. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908–16

    Article  PubMed  CAS  Google Scholar 

  6. Van Rees BP, Ristimäki A. Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol 2001;36:897–903

    Article  PubMed  Google Scholar 

  7. Saukkonen K, Nieminen O, Van Rees B, et al. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin Cancer Res 2001;7:1923–31

    PubMed  CAS  Google Scholar 

  8. Han SL, Tang HJ, Hua YW, Ji SQ, Lin DX. Expression of COX-2 in stomach cancers and its relation to their biological features. Dig Surg 2003;20:107–14

    Article  PubMed  CAS  Google Scholar 

  9. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4–6

    Article  PubMed  CAS  Google Scholar 

  10. Ribatti D., Vacca A., Dammacco F. The role of the vascular phase in solid tumor growth: a historical review. Neoplasia 1999;1:293–302

    Article  PubMed  CAS  Google Scholar 

  11. Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002;96:1497–506

    Article  CAS  Google Scholar 

  12. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549–80

    Article  PubMed  CAS  Google Scholar 

  13. Kleespies A, Guba M, Jauch KW, Bruns CJ. Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 2004;87:95–104

    Article  PubMed  CAS  Google Scholar 

  14. Shi H, Xu JM, Hu NZ, Xie HJ. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 2003;9:1421–6

    PubMed  CAS  Google Scholar 

  15. Zheng S, Han MY, Xiao ZH, Peng JP, Dong Q. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 2003;9:1227–30

    PubMed  Google Scholar 

  16. Morabito A, Sarmiento R, Bonginelli P, Gasparini G. Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Crit Rev Oncol Hematol 2004;49:91–107

    Article  PubMed  Google Scholar 

  17. Raspollini MR, Amunni G, Villanucci A, Baroni G, Boddi V, Taddei GL. Prognistic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma. Int J Gynecol Cancer 2004;14:815–23

    Article  PubMed  CAS  Google Scholar 

  18. Giatromanolaki A, Sivridis E, Brekken R, et al. The angiogenic “vascular endothelial growth factor/flk-1(KDR) receptor” pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer 2001;92:2569–77

    Article  PubMed  CAS  Google Scholar 

  19. Bremnes RM, Camps C, Sirera R. Angiogenesis in non–small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006;51:143–58

    Article  PubMed  Google Scholar 

  20. Schlingemann RO, Rietveld FJR, de Waal RMW, et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 1990;62:690–6

    PubMed  CAS  Google Scholar 

  21. Hlatky L, Hahnfeltd P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 2002;94:883–93

    PubMed  Google Scholar 

  22. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10–24

    Article  PubMed  Google Scholar 

  23. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004;10:8465–71

    Article  PubMed  CAS  Google Scholar 

  24. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 2000;82:339–47

    Article  PubMed  CAS  Google Scholar 

  25. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8

    Article  PubMed  CAS  Google Scholar 

  26. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474–84

    Article  PubMed  CAS  Google Scholar 

  27. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000;89:1418–24

    Article  PubMed  CAS  Google Scholar 

  28. Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858–63

    Article  PubMed  CAS  Google Scholar 

  29. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997;15:826–32

    PubMed  CAS  Google Scholar 

  30. Joo YE, Rew JS, Seo YH, et al. Cyclooxygenase-2 overexpression correlates with vascular endothelial factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol 2003;37:28–33

    Article  PubMed  CAS  Google Scholar 

  31. Joo YE, Oh WT, Rew JS, Park CS, Choi SK, Kim SJ. Cyclooxygenase-2 Expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion 2002;66:222–9

    Article  PubMed  CAS  Google Scholar 

  32. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19–27

    Article  PubMed  CAS  Google Scholar 

  33. Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000;6:519–25

    PubMed  CAS  Google Scholar 

  34. Schor AM, Pendleton N, Pazouki S, et al. Assesment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours. Histochem J 1998;30:849–56

    Article  PubMed  CAS  Google Scholar 

  35. Yoshida S, Amano H, Hayashi I, et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003;83:1385–94

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan

    Yanislav Kolev MD, Satoru Iida MD, PhD, Toshiaki Ishikawa MD, PhD & Kenichi Sugihara MD, PhD

  2. Translational Oncology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan

    Hiroyuki Uetake MD, PhD

  3. Vascular and Applied Surgery, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan

    Tatsuyuki Kawano MD, PhD

Authors
  1. Yanislav Kolev MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Uetake MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoru Iida MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshiaki Ishikawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuyuki Kawano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenichi Sugihara MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yanislav Kolev MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolev, Y., Uetake, H., Iida, S. et al. Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma. Ann Surg Oncol 14, 2738–2747 (2007). https://doi.org/10.1245/s10434-007-9484-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9484-7

Keywords

Search

Navigation